Secteur TScan Therapeutics, Inc.

Actions

TCRX

US89854M1018

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 18:33:03 27/07/2026 Varia. 5j. Varia. 1 janv.
0,7930 USD -0,13% Graphique intraday de TScan Therapeutics, Inc. -14,28% -20,74%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-0,13%-14,28%-18,92%-39,50%-20,74%-57,61%-62,44%-91,74% - 51,89 M
-1,82%+4,80%+0,56%+16,63%+10,18%+54,32%+68,36%+214,54%+6 022,48% 57,28 Md
-0,27%+5,74%+5,48%+24,56%+37,53%+40,26%+80,17%-16,19% - 54,99 Md
-0,41%-0,56%+1,60%-21,74%-38,85%+4,59%+421,67%+346,96%+836,80% 23,18 Md
+2,92%-0,65%-2,86%-10,28%-3,82%-18,82%-12,80%-67,76% - 22,59 Md
-1,13%+4,54%+17,01%+15,33%+22,96%+22,73%-8,06%-66,96% - 20,46 Md
+1,57%+3,30%+11,03%+11,78%-5,87%+27,41%-29,07%-30,74%+59,93% 17,56 Md
-0,10%+5,57%+22,85%+7,47%+30,93%+38,63%+565,16% - - 15,67 Md
+5,29%0,00%+14,77%+113,80%+182,04%+185,09%+332,66%+1 569,75%+674,23% 14,46 Md
+1,28%+0,97%+3,30%+25,58%+27,93%+26,31%+186,07%+236,76%+540,07% 13,92 Md
+2,36%+3,69%+5,34%+6,80%-4,62%+88,82%+177,83%+549,11%+7 305,87% 12,55 Md
+1,39%+20,33%+7,10%+17,14%+29,86%+432,19%+140,62%+30,73%+1 334,53% 12,06 Md
-0,90%+11,60%+18,37%-25,08%-12,74%-33,87%+153,80%+104,56% - 11,69 Md
+0,40%+2,52%-7,05%+31,66%+27,64%+121,42%+151,64%+188,53%+682,87% 10,96 Md
-1,24%-0,93%-6,60%-39,53%-23,53%-51,28%+593,01%+76,68%+87,06% 10,9 Md
-1,85%+2,05%+10,17%+38,14%+203,19%+484,95%+608,58%-40,08%-15,47% 8,98 Md
+0,09%-0,10%+126,81%+116,95%+79,99%+176,52%+353,87%+374,43% - 8,83 Md
+1,64%+5,67%+29,67%+27,15%+16,37%+26,04%+322,89%+324,67% - 7,92 Md
+1,62%-0,14%-3,98%-7,19%+20,12%+54,52%+19,89%+152,51% - 7,89 Md
-1,20%-7,87%-21,27%-5,28%+248,74%+160,57%+196,35%-35,89% - 7,44 Md
Moyenne +0,48%+0,49%+10,67%+15,22%+41,37%+89,14%+213,01%+201,04%+1 752,84% 16,97 Md
Moyenne pondérée par Capi. +0,18%+1,88%+8,66%+16,54%+30,65%+70,85%+176,79%+184,85%+2 742,76%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action TCRX
  4. Secteur TScan Therapeutics, Inc.